Cargando…
P997: FEDRATINIB IS EFFECTIVE IN RUXOLITINIB-RESISTANT CELLS: CLINICAL AND PRECLINICAL CORRELATIONS
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431518/ http://dx.doi.org/10.1097/01.HS9.0000970892.97539.5e |
| _version_ | 1785091221152071680 |
|---|---|
| author | Jeyaraju, Danny Hayati, Sheida Polonskaia, Ann Browne, Andrew Risueño, Alberto Hagner, Patrick Gupta, Vikas Talpaz, Moshe Hernandez, Christopher Chia, Vincent Brown, Patrick De Menezes, Daniel Lopes La Motte-Mohs, Ross Nvs Suragani, Rajasekhar Gandhi, Anita |
| author_facet | Jeyaraju, Danny Hayati, Sheida Polonskaia, Ann Browne, Andrew Risueño, Alberto Hagner, Patrick Gupta, Vikas Talpaz, Moshe Hernandez, Christopher Chia, Vincent Brown, Patrick De Menezes, Daniel Lopes La Motte-Mohs, Ross Nvs Suragani, Rajasekhar Gandhi, Anita |
| author_sort | Jeyaraju, Danny |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431518 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104315182023-08-17 P997: FEDRATINIB IS EFFECTIVE IN RUXOLITINIB-RESISTANT CELLS: CLINICAL AND PRECLINICAL CORRELATIONS Jeyaraju, Danny Hayati, Sheida Polonskaia, Ann Browne, Andrew Risueño, Alberto Hagner, Patrick Gupta, Vikas Talpaz, Moshe Hernandez, Christopher Chia, Vincent Brown, Patrick De Menezes, Daniel Lopes La Motte-Mohs, Ross Nvs Suragani, Rajasekhar Gandhi, Anita Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431518/ http://dx.doi.org/10.1097/01.HS9.0000970892.97539.5e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Jeyaraju, Danny Hayati, Sheida Polonskaia, Ann Browne, Andrew Risueño, Alberto Hagner, Patrick Gupta, Vikas Talpaz, Moshe Hernandez, Christopher Chia, Vincent Brown, Patrick De Menezes, Daniel Lopes La Motte-Mohs, Ross Nvs Suragani, Rajasekhar Gandhi, Anita P997: FEDRATINIB IS EFFECTIVE IN RUXOLITINIB-RESISTANT CELLS: CLINICAL AND PRECLINICAL CORRELATIONS |
| title | P997: FEDRATINIB IS EFFECTIVE IN RUXOLITINIB-RESISTANT CELLS: CLINICAL AND PRECLINICAL CORRELATIONS |
| title_full | P997: FEDRATINIB IS EFFECTIVE IN RUXOLITINIB-RESISTANT CELLS: CLINICAL AND PRECLINICAL CORRELATIONS |
| title_fullStr | P997: FEDRATINIB IS EFFECTIVE IN RUXOLITINIB-RESISTANT CELLS: CLINICAL AND PRECLINICAL CORRELATIONS |
| title_full_unstemmed | P997: FEDRATINIB IS EFFECTIVE IN RUXOLITINIB-RESISTANT CELLS: CLINICAL AND PRECLINICAL CORRELATIONS |
| title_short | P997: FEDRATINIB IS EFFECTIVE IN RUXOLITINIB-RESISTANT CELLS: CLINICAL AND PRECLINICAL CORRELATIONS |
| title_sort | p997: fedratinib is effective in ruxolitinib-resistant cells: clinical and preclinical correlations |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431518/ http://dx.doi.org/10.1097/01.HS9.0000970892.97539.5e |
| work_keys_str_mv | AT jeyarajudanny p997fedratinibiseffectiveinruxolitinibresistantcellsclinicalandpreclinicalcorrelations AT hayatisheida p997fedratinibiseffectiveinruxolitinibresistantcellsclinicalandpreclinicalcorrelations AT polonskaiaann p997fedratinibiseffectiveinruxolitinibresistantcellsclinicalandpreclinicalcorrelations AT browneandrew p997fedratinibiseffectiveinruxolitinibresistantcellsclinicalandpreclinicalcorrelations AT risuenoalberto p997fedratinibiseffectiveinruxolitinibresistantcellsclinicalandpreclinicalcorrelations AT hagnerpatrick p997fedratinibiseffectiveinruxolitinibresistantcellsclinicalandpreclinicalcorrelations AT guptavikas p997fedratinibiseffectiveinruxolitinibresistantcellsclinicalandpreclinicalcorrelations AT talpazmoshe p997fedratinibiseffectiveinruxolitinibresistantcellsclinicalandpreclinicalcorrelations AT hernandezchristopher p997fedratinibiseffectiveinruxolitinibresistantcellsclinicalandpreclinicalcorrelations AT chiavincent p997fedratinibiseffectiveinruxolitinibresistantcellsclinicalandpreclinicalcorrelations AT brownpatrick p997fedratinibiseffectiveinruxolitinibresistantcellsclinicalandpreclinicalcorrelations AT demenezesdaniellopes p997fedratinibiseffectiveinruxolitinibresistantcellsclinicalandpreclinicalcorrelations AT lamottemohsross p997fedratinibiseffectiveinruxolitinibresistantcellsclinicalandpreclinicalcorrelations AT nvssuraganirajasekhar p997fedratinibiseffectiveinruxolitinibresistantcellsclinicalandpreclinicalcorrelations AT gandhianita p997fedratinibiseffectiveinruxolitinibresistantcellsclinicalandpreclinicalcorrelations |